|
| Exchange Disseminated Time | Neocure Therapeutics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 11, 2006 has taken the following decision:
1. Sale, lease or otherwise dispose of the whole or substantially the whole of the undertaking of the company.
2. Change of name of the Company.
3. Alteration of objects clause of Memorandum and Articles of Association of the company.
4. Commencement of new line of business activity other than existing business of the company.
5. Appointment of Scrutinizer for the purpose of entire postal ballot.
6. Grant of authorization to the Director and Compliance officer / Secretary to be responsible for the entire poll process.
7. Approval of notice of postal ballot.
8. Approval of draft resolution along with postal ballot form and business reply cover to be forwarded to the members. |
|
|